Beyond pills: Cardiologists examine alternatives to halt high blood pressure
More and more, patients show up to appointments with hypertension expert John Bisognano, M.D., Ph.D. carrying bags full of "natural" products that they hope will help lower their blood pressure. And...
View ArticleNovartis chief sees sales dip until mid-2013
Swiss pharmaceutical giant Novartis said Sunday the expiry of a US patent for its leading hypertension drug Diovan caused a drop in turnover that could last into the first half of 2013.
View ArticleNovartis Q4 net profit rebounds to $2.1 billion
(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous...
View ArticleAstaZeneca in patent warning as net profit falls
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in full-year net profit on Thursday.
View ArticleAnti-hypertension drug may improve schizophrenia symptoms
(Medical Xpress)—An anti-hypertension drug administered intravenously for a single four-hour treatment resulted in dramatic improvements of symptoms for people living with schizophrenia, according to...
View ArticleHealthy lifestyle reduces the risk of hypertension by two thirds
Healthy behaviours regarding alcohol, physical activity, vegetable intake and body weight reduce the risk of hypertension by two thirds, according to research presented at the ESC Congress today. The...
View ArticleBangladesh doctors urge Viagra production halt
Bangladeshi doctors Wednesday asked the government to halt permits for Viagra to be mass produced for the domestic market, fearing it could lead to the anti-impotence drug becoming available over the...
View ArticleNearly half of US adults with high blood pressure have it under control
Nearly half of U.S. adults with high blood pressure had their blood pressure under control by the end of 2010—a significant increase from the start of the decade, researchers reported in the American...
View ArticleBlack patients with hypertension not prescribed diuretics enough
A research study of more than 600 black patients with uncontrolled hypertension found that less than half were prescribed a diuretic drug with proven benefit that costs just pennies a day, report...
View ArticleErectile dysfunction drug fails for diastolic heart failure patients
Despite high expectations for a commonly used erectile dysfunction drug to treat patients with diastolic heart failure, no beneficial effects were found in a study presented today at the American...
View ArticleExperts discuss ways to embed patient voices and values in clinical research
There is worldwide concern in the biomedical research community that enrollment in clinical trials is lagging, putting clinical research and consequent benefits to society in jeopardy. Experts explore...
View ArticleCommonly-prescribed drugs may influence the onset and progression of...
Multiple drug classes commonly prescribed for common medical conditions are capable of influencing the onset and progression of Alzheimer's disease, according to researchers at The Mount Sinai Medical...
View ArticleBlocking molecular pathway reverses pulmonary hypertension in rats
Pulmonary hypertension, a deadly form of high blood pressure that develops in the lungs, may be caused by an inflammation-producing molecular pathway that damages the inner lining of blood vessels,...
View ArticlePotential new drug target for cystic fibrosis
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and Regensburg University, both in Germany, and the University of Lisboa, in Portugal, have discovered a promising potential...
View ArticleNew class of drug targets heart disease
(Edmonton) Researchers at the University of Alberta have developed a synthetic peptide that could be the first in a new class of drugs to treat heart disease, high blood pressure and diabetes.
View ArticleAdempas approved to treat pulmonary hypertension
(HealthDay)—Adempas (riociguat) has been approved by the U.S. Food and Drug Administration to treat two types of pulmonary hypertension, characterized by high blood pressure in the arteries of the lungs.
View ArticleOpsumit approved for pulmonary arterial hypertension
(HealthDay)—Opsumit (macitentan) has been approved by the U.S. Food and Drug Administration to treat adults with pulmonary arterial hypertension, a debilitating disease characterized by high blood...
View ArticleAntihypertensives associated with lower dialysis risk for patients with...
Patients with stable hypertension and the most advanced stage of chronic kidney disease (CKD) before dialysis appeared to have a lower risk for long-term dialysis or death if they were treated with the...
View ArticleExploring how kidney failure impacts the body's systems
For the 35,000 Canadians currently on kidney dialysis, several medications – up to a dozen in some cases – are prescribed to control such things as diabetes, hypertension and various types of infection.
View ArticleStandard kidney drug treatment works better than new surgical procedure
A simple surgical procedure on the kidneys touted as a revolutionary treatment for high blood pressure turns out to be not so revolutionary after all. In a first its kind, a Norwegian clinical trial...
View Article
